Table of Contents  
ORIGINAL ARTICLE
Year : 2022  |  Volume : 21  |  Issue : 1  |  Page : 30-39

Ameliorative effect of costus ethanolic extract against Oxaliplatin-induced hepatotoxicity in adult rats


1 Department of Zoology, Faculty of Science, South Valley University, Qena, Egypt
2 Department of Zoology, Faculty of Science, Al-Azhar University, Assiut, Egypt
3 Medical Physiology Department, Medical Division, National Research Centre, Giza, Egypt
4 Pathology Department, Medical Division, National Research Centre, Giza, Egypt

Date of Submission14-Jul-2021
Date of Decision12-Oct-2021
Date of Acceptance13-Oct-2021
Date of Web Publication17-May-2022

Correspondence Address:
Mahmoud Ashry
Department of Zoology, Faculty of Science, Al Azhar University, Assiut
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/epj.epj_44_21

Rights and Permissions
  Abstract 


Background and objective Cancer is a disease associated with an abnormal proliferation and growth of living cells; treatment with the anticancer therapy, Oxaliplatin (OXP) results in hepatotoxicity. The objective of this study was to evaluate the protective effect of costus ethanolic extract (CEE) against OXP-induced hepatotoxicity in a trail to improve its clinical use.
Materials and methods Adult male Wistar rats (150–180 g body weight) were randomly divided into four groups (10 rats each): (a) healthy control group, (b) healthy rats treated orally with CEE (50 mg/kg/day), (c) rats injected intraperitoneally with OXP (10 mg/kg once/week), and (d) rats treated with CEE in combination with OXP.
Results and conclusion After 6 weeks of treatment, the results revealed that CEE succeeded to decline OXP-induced hepatotoxicity; this was evidenced by the significant reduction in serum alanine aminotransferase (ALAT), aspartate aminotransferases (ASAT), GGT, alkaline phosphatase (ALP), total cholesterol, triglycerides, low dense lipoprotein-cholesterol (LDL-c), tumor necrosis factor-alpha (TNF-α), Interleukin -1 Beta (IL-1β), and alpha-fetoprotein values as well as hepatic malondialdehyde, nitric oxide, and DNA fragmentation coupled with a marked rise in serum CD4, albumin and high dense lipoprotein-cholesterol (HDL-c) levels, and hepatic glutathione, superoxide dismutase, and catalase values. These effects agonized the structural restoration of the histological picture of liver. It could be concluded that CEE succeeded to a great extent to counteract the oxidative stress of OXP and protect the liver against its toxic effects; CEE may be considered as a promising supplement-candidate for the protection of liver against the side effects of that anticancer drugs.

Keywords: costus, hepatotoxicity, immunomodulation, Oxaliplatin, rat


How to cite this article:
Elshater AA, Ashry M, Ahmed H, Abdel-Wahhab KG, Morsy FA, Abd-Elstar R. Ameliorative effect of costus ethanolic extract against Oxaliplatin-induced hepatotoxicity in adult rats. Egypt Pharmaceut J 2022;21:30-9

How to cite this URL:
Elshater AA, Ashry M, Ahmed H, Abdel-Wahhab KG, Morsy FA, Abd-Elstar R. Ameliorative effect of costus ethanolic extract against Oxaliplatin-induced hepatotoxicity in adult rats. Egypt Pharmaceut J [serial online] 2022 [cited 2022 Aug 9];21:30-9. Available from: http://www.epj.eg.net/text.asp?2022/21/1/30/339110




  Introduction Top


Drug-induced hepatotoxicity is one of the major concerns in medical practice. Although it is relatively uncommon, drug-induced liver injury is the leading cause of acute liver failure in the world and a major reason for liver transplantation [1].

Oxaliplatin (OXP), a third-generation platinum chemotherapeutic agent, is widely used in the treatment of several cancers such as colorectal cancer and gastric cancer [2]. OXP-based chemotherapy for colorectal liver metastases has increased resection rates and improved outcomes, and is therefore recommended as the first-line basic chemotherapeutic drug [2],[3]. However, OXP-induced liver injury is a primary limiting factor of OXP-based chemotherapy in patients with colorectal liver metastases [4]. Studies have revealed OXP-induced liver injury in patients who underwent preoperative OXP-based chemotherapy, with an incidence rate of 19–78% [5]. Other reports have shown that OXP-induced sinusoidal injury, one of the distinct drug-specific side effects of OXP, is associated with intraoperative bleeding and postoperative morbidity, and early recurrence and decreased overall survival [6]. The pathological features of OXP-induced liver injury include hepatic sinusoidal dilatation, intrahepatic sinus platelet aggregation, hepatic steatosis, and clinically important adverse effects characterized by a bluish hue in the liver, splenomegaly, and thrombocytopenia [7]. To overcome these side effects, an effective adjuvant drug that protects the liver against damage caused by OXP is imperative.

At present, very little is known about the pathophysiological mechanisms that underlie OXP-induced liver injury. OXP has been confirmed to cause liver oxidative stress response through certain known mechanisms. Robinson et al. [8] reported that oxidative stress-related genes (Mt1, HO1, and SOd3) were upregulated in the liver following OXP chemotherapy, indicating that oxidative stress plays an important role in OXP-induced liver injury. By generating reactive oxygen species (ROS), OXP causes a series of reactions, such as oxidative injury of normal hepatocyte mitochondria, as well as injury, falloff, and local edema of sinusoidal endothelial cells, thereby causing chemotherapy-related liver injury [9].

Plants have a long-time history in medicine. For centuries, many people have developed different herbal medicines using locally available plants as a remedy to their numerous health challenges. When these medicinal plants are excessively consumed, they could result in the damage of some body tissues and their functions [10].

Costus (Saussurea costus) commonly known as ‘Kuth’ from the family Asteraceae is an important medicinal plant. Its roots are widely used in folk medicine. Several studies have reported that the root of costus exhibited antimicrobial and anti-nematode activity [11], hepatoprotective activity [12], antiulcer activity [13], and anti-inflammatory activity [14]. The authors reported the presence of caffeic acid derivatives, chlorogenic acid (1S-(1, 3, 4, 5)-3-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyloxy-1, 4, 5-trihydroxycyclohexanecarboxylic acid), in costus for the first time by high performance liquid chromatography (HPLC) [15]. Chlorogenic acid exhibited antioxidant activity [16]. Although the plant has been reported to contain caffeic acid derivatives (like syringic acid and chlorogenic acid), the antioxidant activity of the plant has now been studied for the first time using its ability to scavenge 1,1-diphenyl-2-picrylhydrazyl, nitric oxide (NO), superoxide radicals, along with its ability to inhibit lipid peroxidation and glutathione (GSH) oxidation. This study aimed to evaluate the ameliorative effect of costus ethanolic extract (CEE) against hepatotoxicity induced by OXP.


  Materials and methods Top


Plant materials and extraction

Costus roots were obtained from Imtinan Company, Nasr City, Cairo, Egypt, which were identified and authenticated by scientific botanists. The plant was found carrying a taxonomic serial number 780691. The ethanolic extract of the dry powdered roots was carried out according to the modified method of Filipiak-Szok et al. [17]; 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of CEE was determined using the method previously described [18]. Reducing power of the extract was determined according to the method described by Sethiya et al. [19].

HPLC analysis of phenolic constituents

High performance liquid chromatography (HPLC) analysis was carried out using an Agilent 1260 series. The separation was carried out using Kromasil C18 column (4.6 mm×250 mm id, 5 µm). The mobile phase consisted of water (A) and 0.05% trifluoroacetic acid in acetonitrile (B) at a flow rate of 1 ml/min. The mobile phase was programmed consecutively in a linear gradient as follows: 0 min (82% A), 0–5 min (80% A), 5–8 min (60% A), 8–12 min (60% A), 12–15 min (85% A), and 15–16 min (82% A). The multiwavelength detector was monitored at 280 nm. The injection volume was 10 µl for each of the sample solutions. The column temperature was maintained at 35°C.

Animals and experimental design

Forty adult male albino rats (150–180 g) were obtained from the Animal Colony, National Research Centre, Egypt; the animals were maintained under temperature-controlled (25±1°C) and light-controlled (12/12 h light/dark cycle) conditions with free access to food and water for a week before starting the experiment for acclimatization; the animals received human care in compliance with the standard institution’s criteria according to the procedures approved by the Ethics Committee of the National Research Centre (FWA 00014747) that follows the recommendations of the National Institutes of Health Guide for the Care and Use of Laboratory Animals (publication No. 85-23, revised in 1985). After the animals were acclimatized to experimental room conditions, they were divided randomly into four groups (10 animals each) as follows: group 1 healthy control rats orally received 0.5 ml water for consecutive 6 weeks; group 2 healthy rats orally ingested with CEE (50 mg/kg/day) for six consecutive weeks, group 3 healthy rats intoxicated intraperitoneally with OXP (10 mg/kg/week) for 6 weeks, and group 4 rats intoxicated with OXP combined with ingestion of CEE for 6 weeks at the mentioned doses.

Blood and tissue sampling

At the end of the treatment period (6 weeks), rats were weighed and then fasted overnight. Following anesthesia (inhalation with diethyl ether), blood specimens were withdrawn from the retro-orbital plexus using heparinized and sterile glass capillaries; whole blood specimens were cool centrifuged at 3000 rpm for 10 min and the sera were separated, divided into aliquots, and stored at −80°C till biochemical measurements, which were carried out immediately. Then after blood collection, the animals were killed soon, and then the liver of each animal was dissected out. One part of the liver of each animal was washed in saline, dried, rolled in a piece ofaluminum foil, and stored at −80°C for both biochemical determinations and DNA fragmentation. Another portion of the liver was soaked in formalin-saline (10%) buffer for histopathological processing and microscopic examination.

Biochemical determinations

Serum aspartate aminotransferases (ASAT), alanine aminotransferase (ALAT), alkaline phosphatase (ALP), and GGT activities were determined spectrophotometrically using reagent kits purchased from Human GesellSchaft fur Biochemical und Diagnostic mbH, Germany, while serum total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol, albumin, and total protein levels were determined using reagent kits purchased from DiaSys Diagnostic Systems GmbH, Germany. Serum tumor necrosis factor-alpha (TNF-α), Interleukin -1 Beta (IL-1β), CD4, and αFP concentrations were measured using ELISA kits purchased from SinoGeneClon Biotech Co. Ltd, No.9 BoYuan Road,YuHang District 311112, Hang Zhou, China. Hepatic levels of GSH and NO and activities of superoxide dismutase (SOD) and catalase (CAT) were estimated using reagent kits obtained from Biodiagnostic, Giza, Egypt. However, malondialdehyde (MDA) level was determined chemically as described by Ruiz-Larnea et al. [20].

DNA fragmentation percentage

The percentage of DNA fragmentation was assayed according to the quantitative method used for grading the DNA damage [21].

Histopathology

Paraffin sections of 5 µm thickness were stained with hematoxylin and eosin [22] and investigated by light microscopy.

Statistical analysis

Comparisons between means were carried out using one-way analysis of variance, followed by post hock (Tukey) multiple comparisons test at P value less than or equal to 0.05 according to Steel and Torrie [23].


  Results Top


The yield, radical scavenging activity, and reducing power of the CEE are shown in [Figure 1] and [Figure 2]. Mostly 16 phenolic compounds were identified in CEE using HPLC analysis. The compounds identified were found to include high contents of naringenin, chlorogenic acid, ferulic acid, taxifolin, gallic acid, and caffeic acid ([Figure 3] and [Table 1]).
Figure 1 The yield (%) and radical scavenging activity (%) of three replicates of ethanolic extract of costus dry powdered roots.

Click here to view
Figure 2 Reducing power of three replicates of the ethanolic extract of costus dry powdered roots.

Click here to view
Figure 3 HPLC analysis of phenolic constituents of costus ethanolic extract.

Click here to view
Table 1 Phenolic constituents of ethanolic extract of costus using HPLC analysis

Click here to view


In comparison to the control group, the obtained results showed a significant increase in TNF-α, IL-1β, and alpha-fetoprotein (AFP) level coupled with a significant decrease in CD4 post-OXP intoxication. Interestingly, administration of rats with CEE besides OXP intoxication led to a marked reduction in the measured inflammatory cytokines (TNF-α and IL-1β) and tumor marker (AFP) associated with a significant increase in serum CD4 level to values close to those of the normal control group when compared with OXP-intoxicated animals ([Figure 4]).
Figure 4 Serum TNF-α, IL-1β, CD4, and AFP levels of control, OXP-intoxicated and CEE-treated male albino rats. *Significantly different from the control group, while #significantly different from the OXP-intoxicated group (P≤0.05). CEE, costus ethanolic extract; AFP, alpha-fetoprotein; IL-1β,, Interleukin -1 Beta; OXP, Oxaliplatin; TNF-α, tumor necrosis factor-alpha.

Click here to view


The data in [Table 2] show that the administration of rats with CEE alone did not disturb the activity of serum ASAT, ALAT, ALP and GGT, while OXP injection led to a significant elevation in the activity of these parameters when both groups were compared with the corresponding values of the control group. Favorably, co-ingestion of CEE in line with OXP injection significantly ameliorated the OXP-induced deteriorations in the mentioned parameters.
Table 2 Markers of liver function of control, Oxaliplatin-intoxicated and costus ethanolic extract-treated male albino rats

Click here to view


Similarly, [Table 2] shows a significant decrease in serum total protein and albumin levels was noticed post-OXP intoxication compared with the control group. Interestingly, administration of rats with CEE besides OXP injection markedly upregulated serum total proteins and albumin levels close to values of the normal group compared withOXP-intoxicated rats.

The obtained results of the OXP-intoxicated group showed a significant increase in total cholesterol, triglycerides, LDL-cholesterol level coupled with a significant decrease in HDL-cholesterol when compared with the control group. Interestingly, treatment of rats with OXP in line with CEE markedly ameliorated serum levels of cholesterol, triglycerides, LDL-cholesterol, and HDL-cholesterol compared with OXP animals ([Table 3]).
Table 3 Serum cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol levels of control, Oxaliplatin-intoxicated and costus ethanolic extract-treated male albino rats

Click here to view


[Table 3] shows that intoxication of rats with OXP led to a significant elevation in the levels of hepatic MDA and NO matched with a marked drop in GSH, SOD, and CAT values compared with the control group. Promisingly, treatment of animals with CEE besides OXP injection showed a significant decrease in hepatic MDA and NO levels coupled with a marked restoration in GSH, SOD, and CAT values compared with the OXP group ([Table 4]).
Table 4 Hepatic values of malondialdehyde, nitric oxide, reduced glutathione, superoxide dismutase, and catalase of control, Oxaliplatin-intoxicated and costus ethanolic extract-treated male albino rats

Click here to view


OXP-intoxicated treatment showed a significant increase in the percent of DNA fragmentation as compared with the control group, whereas treatment of OXP-intoxicated animals with CEE resulted in a significant improvement in DNA fragmentation percentage close to that of the control group ([Figure 5]). Finally, [Figure 6],[Figure 7],[Figure 8],[Figure 9],[Figure 10],[Figure 11] describe and illustrate histopathological examinations of the liver sections of the study groups.
Figure 5 Percentage of hepatic DNA fragmentation of control, OXP-intoxicated and CEE-treated male albino rats. *Significantly different from the control group, while #significantly different from the OXP group. CEE, costus ethanolic extract; OXP, Oxaliplatin.

Click here to view
Figure 6 Photomicrograph of a liver section of a control rat showing the normal appearance of hepatocytes (NH); note the central vein (CV) and normal blood sinusoids (BS).

Click here to view
Figure 7 Photomicrograph of a liver section of a rat treated with CEE showing normal hepatic architecture (NH); note the central vein (CV) and blood sinusoids. CEE, costus ethanolic extract.

Click here to view
Figure 8 Photomicrograph of a liver section of Oxaliplatin-intoxicated rat showing the fibrous tissue (FT), fibrous bands formed of many fibroblasts, and collagen fibers; the bands run in septa between the hepatocyte lobules and around the blood vessels (BV).

Click here to view
Figure 9 Photomicrograph of a liver section of Oxaliplatin-intoxicated rat (second filed) showing signs of degeneration in the form of pyknotic (P) nuclei (PC) and karyorrhexis (yellow arrow).

Click here to view
Figure 10 Photomicrograph of a liver section of Oxaliplatin-intoxicated rat (third filed) showing massive vacuolar (VD) and fatty changes (green arrow) and dilated blood sinusoids (red arrow).

Click here to view
Figure 11 Photomicrograph of a liver section of rats treated with Oxaliplatin combined with CEE showing the normal architecture of hepatocyte (NH), and thick fibrous band (star), formed of many fibrous bands and collagen around the blood vessel (arrow). CEE, costus ethanolic extract.

Click here to view



  Discussion Top


OXP, like chemotherapeutic agents, has been used broadly in the treatment of various cancers and some inflammatory diseases. One of the serious adverse effects of OXP is hepatotoxicity; approaches to reduce this complication are valuable in order to improve the quality of life of patients, and to ensure that treatment is more successful [24]. In the present study, OXP-induced hepatotoxicity is evident by the markedly increased activities of serum ALAT, ASAT, ALP, and GGT along with the declined albumin levels. These findings are in agreement with some recent studies that demonstrate increased liver marker enzymes in the serum of OXP-intoxicated rats [25],[26].The elevated serum enzymes might be attributed to the increase of oxidative stress as a consequence of triggering ROS formation as a consequence to OXP. Moreover, it has been detected that OXP-induced toxicity is associated with an increase in lipid peroxidation, which is one of the most important destructive elements damaging cell membrane in many organs such as the liver and kidneys [24],[27]; OXP-induced hepatic damage associated with progressive inflammation is referred to as chemotherapy-associated steatohepatitis [28].

In this study, CEE showed a hepatoprotective effect against OXP-induced liver damage as it succeeded to efficiently restore OXP-induced elevation of serum AST, ALT, GGT, and ALP activities. It was stated that natural antioxidants play a major role in reducing the oxidative stress through scavenging the excess free radicals [29], and CEE is one of the antioxidant-rich medicinal plants. Moreover, many authors have reported that the roots of this plant possess a cortisol-lowering effect [30]. Costunolide and dehydrocostuslactone, two natural sesquiterpene lactones, present in costus may play some pivotal roles through conjugation with mercapto (SH)-groups of target proteins to intervene in some key biological processes in cells [31] as they possess anti-inflammatory [32], anticancer [33], antiviral [34], antimicrobial [35], antifungal [36], antioxidant [37], antidiabetic [38], antiulcer [39], and hepatoprotective properties [30]. In this study, triglycerides, the main form in which fat is stored in the body, have been shown to be reduced by the CEE indicating CEE-protective effect against cardiovascular disease since this result goes in line with the observation of Duze et al. [40]. The increased serum HDL-cholesterol level observed in our study confirmed that effect as it is considered one of the strongest predictors of coronary heart disease (CHD) [41]. Although the mechanism of hypolipidemic effect of this extract is not yet known, it may however be attributed to its phytochemical constituents inherent that may have reduced blood lipids by competing with cholesterol biosynthesis in the liver and inhibiting the key enzyme hydroxyl-methyl-glutaryl coenzyme at the regulatory site.

The present study demonstrated that OXP-induced chronic oxidative stress in the hepatic tissues of intoxicated rats as confirmed by the significant increase of hepatic MDA and NO levels and reduction in the antioxidative battery (GSH, SOD, and CAT) can directly promote cell necrosis and activate the apoptotic pathway [42]. Excessive amounts of ROS may exert direct deleterious effects on cells through lipid peroxidation, protein degradation, and DNA damage [43], which evidenced herein by way of the elevated DNA damage percentage. Interestingly, CEE succeeded to protect against OXP as it markedly improved the radical scavenging activity, and hence inhibited oxidative stress progression. Restoration of GSH has a multifaceted role in antioxidant defense both as a direct scavenger of free radicals and as a co-substrate for peroxide detoxification by GSH peroxidases [44]. Also, SOD and CAT function in a sequential cascade manner in the antioxidant defense system. As an antioxidant enzyme, SOD catalyzes the removal of superoxide radicals generated from the oxidation of a singlet oxygen species. The end product of SOD action is hydrogen peroxide, which is an inhibitor of SOD if allowed to accumulate. Hydrogen peroxide is also a substrate for the production of hydroxyl radicals through the Fenton reaction cycle; hence this is the importance of CAT in the breakdown of hydrogen peroxide as it is formed of water and oxygen [45]. In this way, CEE causes activation of SOD and CAT function in protecting the cell from oxidative stress [46],[47].

AFP gene is reactivated during hepatocarcinogenesis; cytoplasmic AFP enhances the proliferation of malignant hepatocytes, while extracellular AFP accelerates the growth of malignant hepatocytes through AFP receptors [48]. Besides hepatocytes, liver progenitor cells also develop AFP during their cellular differentiation [49]. Elevation of serum AFP is indicative of the proliferation of liver progenitor cells as a response to chronic liver injury [50]. Our study showed a significant elevation in serum AFP and CD4 levels after injection with OXP compared with normal control rats; this result agrees with previous studies [51],[52]. This may be attributed to the activation of AFP gene and elevation in its serum level. Helper CD4+ T cells play a role in adaptive immunity by conditioning the environment and modulating the activity of other immune cells through cytokine production [53]. In the same way, the levels of the hepatic inflammatory cytokines, TNF-α and IL-1β, were increased markedly after OXP injection. Both inflammatory cytokines have been shown to cause hepatocyte injury through triggering a potent cytotoxic immune response and cell death [54]. TNF-α acts as a pivotal mediator in the progression of acute liver injury; consequently, its overproduction activates caspase-3, a member of the family of cysteine proteases, which, in turn, triggers hepatocellular necrosis and the apoptotic pathway [55]. Excessive ROS generation activates the JNK and caspase pathways, ultimately leading to TNF-α-induced cell death [56]. Oxidative stress also promotes the migration of inflammatory cells across the endothelial barrier, leading to tissue injury [57]. Therefore, it is reasonable to hypothesize that oxidative stress, which is exacerbated by OXP, may contribute to the rapid increase in the production of inflammatory cytokines in rats after OXP intoxication further aggravating liver injury, which mostly could be mechanized through the activation of AFP gene and helper CD4 T cells. In a promising manner, treatment of rats with CEE besides OXP potentially reduced OXP-induced inflammation, as it valuably decreased the level of serum TNF-α, IL-1β, CD4, and AFP. These were released from activated macrophages at the site of inflammation and influence hepatic metabolism by upregulating acute-phase protein gene expression [58]; this anti-inflammatory effect suggests that CEE may have genetic and immunomodulatory properties. Phytochemical analysis of the crude CEE showed that its main chemical constituents are phenolics and flavonoids, which have antioxidant effects, and these results are in agreement with previous reports [59]. The biochemical findings of our study are matched with the histopathological one, which proved that OXP causes liver damage as evidenced by the observation of necrotic hepatocytes with small degeneration in the form of pyknotic nuclei, and karyorrhexis, a portal space with severe inflammation, dilated blood sinusoids, and hepatocytes surrounded by lymphocytic infiltration; these architectural deteriorations might be caused by the membrane-damaging potential of OXP metabolites through oxidative stress mechanisms. These pathological changes directly correlated with the deteriorated biochemical and inflammatory markers, and were supported by a recent study [25]. Favorably, CEE administration effectively alleviated the OXP-induced hepatic histopathological changes and seemed to protect the liver tissue from OXP-induced acute oxidative stress possibly through antioxidant activities [60]. It has been established that ROS are involved in inflammation [32] and the protective action of CEE against OXP-resultant hepatic damage could involve anti-inflammatory, anti-dyslipidemia, and antioxidant mechanisms related to scavenging activity of ROS produced by OXP.


  Conclusion Top


In conclusion, our results indicate that CEE was able to significantly ameliorate OXP-induced liver damage through anti-inflammatory, anti-dyslipidemia, and antioxidant mechanisms of its inherited constituents. CEE might be effective against different illnesses associated with the liver and can help in the management strategy of long-term use of OXP to help relieve patients of pain.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a US multicenter, prospective study. Hepatology 2010; 52:2065–2076.  Back to cited text no. 1
    
2.
Riddell IA. Cisplatin and oxaliplatin: our current understanding of their actions. Met Ions Life Sci 2018; 18:1.  Back to cited text no. 2
    
3.
Jardim DL, Rodrigues CA, Novis YA, Rocha VG, Hoff PM. Oxaliplatin-related thrombocytopenia. Ann Oncol 2012; 23:1937–1942.  Back to cited text no. 3
    
4.
Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le charpentier M et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15:460–466.  Back to cited text no. 4
    
5.
Vauthey JN, Pawlik TM, Ribero D, Wu T-T., Zorzi D, Hoff PM et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24:2065–2072.  Back to cited text no. 5
    
6.
Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 2011; 18:421–430.  Back to cited text no. 6
    
7.
Tajima H, Ohta T, Miyashita T, Nakanuma S, Matoba M, Miyata T et al. Oxaliplatin-based chemotherapy induces extravasated platelet aggregation in the liver. Mol Clin Oncol 2015; 3:555–558.  Back to cited text no. 7
    
8.
Robinson SM, Mann J, Vasilaki A, Mathers J, Burt AD, Oakley F, White SA, Mann DA. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. J Hepatol 2013; 59:318–326.  Back to cited text no. 8
    
9.
Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 2009; 10:278–286.  Back to cited text no. 9
    
10.
Soladoye MO, Amusa NA, Raji-Esan SO, Chukwuma EC, Taiwo AA. Ethnobotanical survey of anti-cancer plants inOgun State, Nigeria. Ann Biol Res 2010; 1:261–273.  Back to cited text no. 10
    
11.
Naik SN, Kumar A, Maheswari RC, Guddewar MB, Chandra R, Kumar B. Pesticidal properties of sub-critically extracted plant essential oils against storage pest Tribolium castaenium (herbest). Indian Perfumer 1995; 39:171–176.  Back to cited text no. 11
    
12.
Okugawa H, Ueda R, Matsumoto K, Kawanishi K, Kato A. Effect of dehydrocostus lactone and costunolide from Saussurea root on the central nervous system in mice. Phytomedicine 1996; 3:147–153.  Back to cited text no. 12
    
13.
Yamahara J, Kobayashi M, Miki K, Kozuka M, Sawada T, Fujimura H. Cholagogic and antiulcer effect of saussureae radix and its active components. Chem Pharm Bull (Tokyo) 1985; 33:1285–1288.  Back to cited text no. 13
    
14.
Jin M, Lee HJ, Ryu JH, Chung KS. Inhibition of lps − induced NO productiion abdTNF − kappaB activation by a sesquiterpene from Saussurea lappa. Arch Pharmacol Res 2000; 23:54–58.  Back to cited text no. 14
    
15.
Pandey MM, Govindrajan R, Rawat AKS, Pangtey YPS, Mehrotra S. High performance liquid chromatographic method for quantitative estimation of an antioxidant principle chlorogenic acid in Saussurea costus and Arctium lappa. J Natl Prod Sci 2004; 10:40–42.  Back to cited text no. 15
    
16.
Shafiee A, Sayadi A, Roozbahani MH, Foroumadi A, Kamal F. Synthesis and in vitro antimicrobial evaluation of 5‐(1‐Methyl‐5‐nitro‐2‐imidazolyl)‐4H‐1, 2, 4‐triazoles. Int J Pharma Med Chem 2002; 335:495–499.  Back to cited text no. 16
    
17.
Filipiak-Szok A, Kurzawa M, Szłyk E, Twarużek M, Błajet-Kosicka A, Grajewski J. Determination of mycotoxins, alkaloids, phytochemicals, antioxidants and cytotoxicity in Asiatic ginseng (Ashwagandha, Dong quai, Panax ginseng). Chem Papers 2017; 71:1073–1082.  Back to cited text no. 17
    
18.
Nogala-Kalucka M, Korczak J, Dratwia M, Lampart-Szczapa E, Siger A, Buchowski M. Changes in antioxidant activity and free radical scavenging potential of rosemary extract and tocopherols in isolated rapeseed oil triacylglycerols during accelerated tests. Food Chem 2005; 93:227–235.  Back to cited text no. 18
    
19.
Sethiya NK, Trivedi A, Mishra S. The total antioxidant content and radical scavenging investigation on 17 phytochemical from dietary plant sources used globally as functional food. Biomed Prev Nutr 2014; 4:439–444.  Back to cited text no. 19
    
20.
Ruiz-Larnea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2 hydroxyestradiol on iron induced lipid peroxidation of rat liver microsome. Steroids 1994; 59:383–388.  Back to cited text no. 20
    
21.
Perandones CE, Illera VA, Peckham D, Stunz LL, Ashman RF. Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol 1993; 151:3521–3529.  Back to cited text no. 21
    
22.
Drury RAB, Wallington EA. Preparation and fixation of tissues. In: Drury RAB, Wallington EA, editors. Carleton ’s histological technique. 5 Oxford: Oxford University Press 1980. pp. 41–54.  Back to cited text no. 22
    
23.
Steel RG, Torrie GH. Principles and procedures of statistics: a biometrical approach. New York: McGraw-Hill 1980. p. 633.  Back to cited text no. 23
    
24.
Demirci T, Gedikli S, Ozturk N, Aydemir Celep N. The protective effect of N-acetylcysteine against methotrexate-induced hepatotoxicity in rat. EJMI 2019; 3:219–226.  Back to cited text no. 24
    
25.
Ulain1 N, Bano N, Beg AE, Hameed K, Fayyaz T, Sadaf R. Hepatoprotective effects of ethanolic extract of Boerhaavia diffusa against oxaliplatin induced hepatotoxicity in albino rats. Pak J Pharm Sci 2019; 32:1927–1932.  Back to cited text no. 25
    
26.
Lu Y, Wu S, Xiang B, Li L, Lin Y. Curcumin attenuates oxaliplatin-induced liver injury and oxidative stress by activating the Nrf2 pathway. Drug Des Dev Ther 2020; 14:73–85.  Back to cited text no. 26
    
27.
Bano N, Najam R. Histopathological and biochemical assessment of liver damage in albino Wistar rats treated with cytotoxic platinum compounds in combination with 5-fluorouracil. Arch Med Sci 2019; 15:1092–1103.  Back to cited text no. 27
    
28.
Schwingel TE, Klein CP, Nicoletti NF, Dora CL, Hadrich G, Bica CG et al. Effects of the compound sresveratrol, rutin, quercetin and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice. Naunyn Schmiedebergs Arch Pharmacol 2014; 387:837–848.  Back to cited text no. 28
    
29.
Ahmad S, Khan MB, Hoda MN, Bhatia K, Haque R, Fazili IS. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. Neurochem Res 2012; 37:516–526.  Back to cited text no. 29
    
30.
Ambavade SD, Mhetre NA, Tate VD, Bodhankar SL. Pharmacological evaluation of anxiolytic effect of aqueous extracts of Saussurea lappa roots in mice. Eur J Integr Med 2009; 1:131–137.  Back to cited text no. 30
    
31.
Jeong GS, Pae HO, Jeong SO, Kim YC, Kwon TO, Lee HS et al. The α-methylene-γ-butyrolactone moiety in dehydrocostus lactone is responsible forcytoprotective heme oxygenase-1 expression through activation of the nuclear factor E2-related factor 2 in HepG2 cells. Eur J Pharmacol 2007; 565:37–44.  Back to cited text no. 31
    
32.
Butturini E, di Paola R, Suzuki H, Paterniti I, Ahmad A, Mariotto S, Cuzzocrea S. Costunolide and dehydrocostuslactone, two natural sesquiterpene lactones, ameliorate the inflammatory process associated to experimental pleurisyinmice. Eur J Pharmacol 2014; 730:107–115.  Back to cited text no. 32
    
33.
Kuo PL, Ni WC, Tsai EM, Hsu YL. Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells. Mol Cancer Ther 2009; 8:1328–1339.  Back to cited text no. 33
    
34.
Chen HC, Chou CK, Lee SD, Wang JC, Yeh SF. Active compounds from Saussurea lappa clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antivir Res 1995; 27:99–109.  Back to cited text no. 34
    
35.
Lee HK, Song HE, Lee HB, Kim CS, Koketsu M, Ngan LT, Ahn YJ. Growth inhibitory, bactericidal, and morphostructural effects of dehydrocostus lactone from Magnolia sieboldii leaves on antibiotic-susceptible and resistant strains of Helicobacter pylori. PLoS ONE 2014; 9:95530.  Back to cited text no. 35
    
36.
Barrero AF, Oltra JE, Alvarez M, Raslan DS, Saude DA, Akssira M. New sources and antifungal activity of sesquiterpene lactones. Fitoterapia 2000; 71:60–64.  Back to cited text no. 36
    
37.
Seo MS, Choi EM. The effects of dehydrocostus lactone on osteoblastic MC3T3-E1 cells in redox changes and PI3K/Akt/CREB. Immunopharmacol Immunotoxicol 2012; 34:810–814.  Back to cited text no. 37
    
38.
Upadhyay OP, Singh RH, Dutta SK. Studies on antidiabetic medicinal plants used in Indian folklore. Aryavaidyan 1996; 9:159–167.  Back to cited text no. 38
    
39.
Sutar N, Garai R, Sharma US, Singh N, Roy SD. Antiulcerogenic activity of Saussurea lappa root. Int J Pharm Life Sci 2011; 2:516–520.  Back to cited text no. 39
    
40.
Duze BN, Sewani-Rusike CR, Nkeh-Chungag BN. Effects of an ethanolic extract of Garcinia kola on glucose and lipid levels in streptozotocin induced diabetic rats. Afr J Biotechnol 2012; 11:8309–8315.  Back to cited text no. 40
    
41.
Maria PS, Ronald BG. Lipid management in type 2 diabetes. Clin Diab 2006; 24:27–32.  Back to cited text no. 41
    
42.
Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non‑alcoholic steatohepatitis. Clin Chim Acta 2011; 412:1297–1305.  Back to cited text no. 42
    
43.
Chen Y, dong H, Thompson DC, Shertzer HG, Nebert DW, Vasiliou V. Glutathione defense mechanism in liver injury: Insights from animal models. Food Chem Toxicol 2013; 60:38–44.  Back to cited text no. 43
    
44.
Ewis SA, Abdel‐Rahman MS. Effect of metformin on glutathione and magnesium in normal and streptozotocin‐induced diabetic rats. J Appl Toxicol 1995; 15:387–390.  Back to cited text no. 44
    
45.
Tao Z, Raffel RA, Souid AK, Goodisman J. Kinetic studies on enzyme-catalyzed reactions: Oxidation of glucose, decomposition of hydrogen peroxide and their combination. Biophys J 2009; 96:2977–2988.  Back to cited text no. 45
    
46.
Ha H, Lee HB. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology 2005; 10:7–10.  Back to cited text no. 46
    
47.
Tchamgoue AD, Tchokouaha LRY, Tarkang PA, Kuiate JR, Agbor GA. Costus afer possesses carbohydrate hydrolyzing enzymes inhibitory activity and antioxidant capacity in vitro. Evid Based Complement Alternat Med 2015; 2015:10.  Back to cited text no. 47
    
48.
Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med 2016; 20:549–558.  Back to cited text no. 48
    
49.
Sell S, Leffert HL. Liver cancer stem cells. J Clin Oncol 2008; 26:2800–2805.  Back to cited text no. 49
    
50.
Ambade A, Satishchandran A, Gyongyosi B, Lowe P, Szabo G. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World J Gastroenterol 2016; 22:4091–4108.  Back to cited text no. 50
    
51.
Mohamed NZ, Aly HF, El-Mezayen H.A., El-Salamony HE. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicol Rep 2019; 6:875–888.  Back to cited text no. 51
    
52.
Stojanovska V, Prakash M, McQuade R, Fraser S, Apostolopoulos V, Sakkal S, Nurgali K. Oxaliplatin treatment alters systemic immune responses. Biomed Res Int 2019; 4650695:15.  Back to cited text no. 52
    
53.
Luckheeram RV, Zhou RI, Verma AD, Xia B. CD4+T cells: differentiation and functions. Clin Dev Immunol 2012; 925135:12.  Back to cited text no. 53
    
54.
Del C, José A, Gallego P, Lourdes G. Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol 2018; 10:1.  Back to cited text no. 54
    
55.
Gao S, Duan X, Wang X, Dong D, Liu D, Li X, Sun G, Li B. Curcumin attenuates arsenic-induced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion. Food Chem Toxicol 2013; 59:739–747.  Back to cited text no. 55
    
56.
Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003; 115:61–70.  Back to cited text no. 56
    
57.
Van Wetering S, van Buul JD, Quik S, Mul FP, Anthony EC, ten Klooster JP et al. Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 2002; 115:1837–1846.  Back to cited text no. 57
    
58.
Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress—induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 2001; 50:404–410.  Back to cited text no. 58
    
59.
Tag HM, Khaled HE, Ismail HAA, El-Shenawy NS. Evaluation of anti-inflammatory potential of the ethanolic extract of the Saussurea lappa root (costus) on adjuvant-induced monoarthritis in rats. J Basic Clin Physiol Pharmacol 2016; 27:71–78.  Back to cited text no. 59
    
60.
Al-Duais MAH, Al-Awthan YSM. Hepatoprotective effect of costus roots extract against carbon tetrachloride (CCl4)-induced liver injury in guinea pigs. J Life Sci 2017; 11:176–184.  Back to cited text no. 60
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9], [Figure 10], [Figure 11]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  Materials and me...
  In this article
Abstract
Introduction
Results
Discussion
Conclusion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed364    
    Printed27    
    Emailed0    
    PDF Downloaded75    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]